Novel Agents and Management Strategies in Endocrinology
Series Overview
From Theory to Practice : Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP). The 2015 program is also approved by BPS for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS). Clinical pharmacists who are board certified in both the pharmacotherapy and ambulatory care pharmacy specialties and who successfully complete the associated recertification test will receive credit toward recertification in both specialties.
This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.
Program Content
“Novel Agents and Management Strategies in Endocrinology” provides a critical review of the clinical evidence on the various agents approved for the management of type 2 diabetes and obesity, and discuss implications on pharmacist patient-care services.
“Novel Agents and Management Strategies in Endocrinology” covers the following content:
- Type 2 Diabetes: Critical Review of the Evidence and Application to Patient Care
- First-in-class, Novel, and New Drugs and Delivery Systems for the Management of Type 2 Diabetes
- Obesity: New Management Strategies
- Practice Management and Pharmacist Services
- Patient Cases
Faculty
|
Benjamin N. Gross, Pharm.D., BCPS, BCACP, CDE, BC-ADM
Associate Professor
Lipscomb University
College of Pharmacy and Health Sciences
Nashville, Tennessee |
|
Emily McCoy Armstrong, Pharm.D., BCACP
Assistant Clinical Professor
Auburn University
Harrison School of Pharmacy
Mobile, Alabama |
|
M. Shawn McFarland, Pharm.D., FCCP, BCPS, BCACP
Associate Service Chief of Pharmacy
Clinical & Educational Programs
VA Tennessee Valley Healthcare System
Associate Professor
University of Tennessee College of Pharmacy
Murfreesboro, Tennessee |
|
Jennifer M. Trujillo, Pharm.D., BCPS, CDE
Associate Professor
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy & Pharmaceutical Sciences
Aurora, Colorado |
Target Audience and Program Goals
The target audience for this program is clinical pharmacists, BCACPs and BCPSs providing care to patients with type 2 diabetes and obesity.
At the conclusion of the program, the participant should be able to:
- Compare and contrast the various agents approved for the management of type 2 diabetes and obesity.
- Critically appraise the published evidence on the treatment of patients with type 2 diabetes and obesity.
- Given a patient case, recommend a management plan for type 2 diabetes and obesity.
- Employ strategies to advance pharmacist services.
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This is an application-based activity; Activity Number: 0217-0000-15-110-H01-P.
To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 14, 2018. Partial credit is not available for this activity.
BCACP/BCPS Specialty Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCACPs and BCPSs must successfully complete a Web-based posttest by November 30, 2015. Partial credit is not available for this activity.
ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.
Technical Requirements
Requires an Internet browser and Adobe Reader.
Fees
Description |
Price |
Nonmember |
Cart |
Specialty Recertification Program with 6.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is November 30, 2015. |
$250 |
$365 |
Expired |
Online Program with 6.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 14, 2018. |
$199 |
$315 |
Expired |